Melanoma Metastasized to the Brain and Steroids

NCT03563729 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: Pembrolizumab Injection [Keytruda]
DRUG: Ipilimumab Injection [Yervoy]
DRUG: Nivolumab Injection [Opdivo]
DRUG: Encorafenib
DRUG: Binimetinib
DRUG: Dabrafenib
DRUG: Trametinib

Sponsor

Inge Marie Svane